Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $26.04 USD
Change Today +0.53 / 2.08%
Volume 305.5K
As of 5:20 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc D. Beer

Chief Executive Officer and Director, Aegerion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 58 board members in 5 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Marc D. Beer has been the Chief Executive Officer at Aegerion Pharmaceuticals, Inc. since August 19, 2010. Mr. Beer founded ViaCell, Inc., and served as its President and Chief Executive Officer from April 2000 to November 2007. Prior to that, from April 1996 to 2000, he held marketing and business development roles at Genzyme Corporation, Sanofi pharmaceutical company, served as Vice President of Global Marketing. From 1996 to April 2000, he served as Senior Manager ...

Read Full Background

Corporate Headquarters*

One Main Street
Cambridge, Massachusetts 02142

United States

Phone: 617-500-7867
Fax: 617-945-7968

Board Members Memberships*

Former Chief Executive Officer, President and Director
Chief Executive Officer and Director
Former Director
Chairman of The Board


Miami University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$584,200

Stock Options*

All Other Compensation$7,650
Exercised Options143,380
Exercised Options Value$12,201,534
Exercisable Options704,545
Exercisable Options Value$46,482,448
Unexercisable Options342,728
Unexercisable Options Value$19,092,743
Total Value of Options$91,170,900
Total Number of Options1,468,153

Total Compensation*

Total Annual Cash Compensation$1,161,445
Total Short Term Compensation$584,200
Other Long Term Compensation$7,650
Total Calculated Compensation$7,036,536
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEGR:US $26.04 USD +0.53


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AEGERION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at